Back
Protara Therapeutics Stock Price Chart
Sponsored
TARA
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
57
TARA
Protara Therapeutics
Last Price:
2.60
Seasonality Move:
31.48%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARA is experiencing slight selling pressure.
Protara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.53 | Buy |
20-day SMA: | 2.24 | Buy |
50-day SMA: | 1.99 | Buy |
200-day SMA: | 2.68 | Sell |
8-day EMA: | 2.49 | Buy |
20-day EMA: | 2.3 | Buy |
50-day EMA: | 2.13 | Buy |
200-day EMA: | 2.35 | Buy |
Protara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 68.29 | Buy |
Chaikin Money Flow: | -5837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 2.47) | Buy |
Bollinger Bands (100): | (1.83 - 2.31) | Buy |
Protara Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protara Therapeutics Stock
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 2.58 while TARA 8-day simple moving average is 2.53, which is a Buy signal.
- The stock price of TARA is 2.58 while Protara Therapeutics 20-day SMA is 2.24, which makes it a Buy.
- Protara Therapeutics 50-day simple moving average is 1.99 while TARA share price is 2.58, making it a Buy technically.
- TARA stock price is 2.58 and Protara Therapeutics 200-day simple moving average is 2.68, creating a Sell signal.
TARA Technical Analysis vs Fundamental Analysis
Buy
57
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a Buy
The current Protara Therapeutics [TARA] share price is $2.58. The Score for TARA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Protara Therapeutics Stock Info
Market Cap:
53.22M
Price in USD:
2.58
Share Volume:
88.38K
Protara Therapeutics 52-Week Range
52-Week High:
5.24
52-Week Low:
1.04
Buy
57
Protara Therapeutics (TARA)
is a Buy
Protara Therapeutics Share Price Forecast
-
What is the Protara Therapeutics stock price today?
The Protara Therapeutics stock price is 2.58 USD today. -
Will TARA stock go up or go down?
Protara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics is not overvalued.
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 2.58 while TARA 8-day exponential moving average is 2.49, which is a Buy signal.
- The stock price of TARA is 2.58 while Protara Therapeutics 20-day EMA is 2.30, which makes it a Buy.
- Protara Therapeutics 50-day exponential moving average is 2.13 while TARA share price is 2.58, making it a Buy technically.
- TARA stock price is 2.58 and Protara Therapeutics 200-day simple moving average is 2.35, creating a Buy signal.
Fundamental Analysis of Protara Therapeutics
Is Protara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.27 per share, and an increase next year of $0.02 per share.
Technical Analysis of Protara Therapeutics
Should I short Protara Therapeutics stock?
- TARA Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Protara Therapeutics is a Buy
- Protara Therapeutics Relative Strength Index (RSI) is 68.29, which suggest Protara Therapeutics is overbought
- The Bollinger Bands (25) for Protara Therapeutics is (1.79 - 2.47), which suggest Protara Therapeutics is a Buy
- The Bollinger Bands (100) for Protara Therapeutics is (1.83 - 2.31), which suggest Protara Therapeutics is a Buy
* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.